Abstract
Objective: Photodynamic therapy (PDT) is an alternative treatment for a variety of malignancies. Application of PDT in the treatment of gynecologic malignancies has been limited, however preliminary results are promising. PDT involves administering a systemic injection of Photofrin II, a selective tumor photosensitizer hematoporphyrin derivative, followed by exposure of tumor tissue to visible light at 630nm. The photodynamic destruction of tumor exhibits both cytocidal and vascular effects that may contribute to the tumorcidal effects observed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
